Abstract:Objective: To compare the clinical effect of different total prostate volume (TPV) and different transitional zone volume (TZV) on benign prostatic hyperplasia (BPH) treated with transurethral resection of prostate(TURP). Methods: Clinical data of 210 patients with BPH admitted to Guizhou provincial people's hospital from June 2016 to August 2018 were retrospectively collected and analyzed. All patients underwent transrectal ultrasonography, and they were divided into three groups according to TPV: 70 patients in group A:TPV<40mL, 98 patients in group B: 40 ml≤TPV<80 ml, and 42 patients in group C:TPV≥80 ml. Meanwhile, three groups were divided according to TZV: 88 patients in group a: TZV<20ml, 67 patients in group b: 20 ml≤TZV<40 ml, and 55 patients in group c:TZV≥40 ml. All of the patients with TURP were followed up for 6 months after surgery, and the data of international prostate symptom score (IPSS), storage symptoms IPSS (IPSS-S), voiding symptoms IPSS (IPSS-V), Quality of Life (QoL) index, and maximum urinary flow rate (Qmax) were collected before and after surgery. Finally, the effect of TPV and TZV on TURP was analyzed respectively by analysis of variance. Results: There were no statistically significant differences in preoperative IPSS, IPSS-V, IPSS-S, QoL and Qmax among the three groups of patients grouped by TPV (P>0.05), but the age of patients in group C(73.5±6.5) was significantly higher than that in group A (69.3±7.6) and group B (70.9±7.3) (P=0.015). Postoperative IPSS, IPSS-V, IPSS-S, QoL and Qmax of patients in groups A, B and C also showed no significant difference (P>0.05). There were no statistically significant differences in preoperative IPSS, IPSS-V, IPSS-S, QoL, and Qmax among the three groups of patients grouped according to TZV (P>0.05), while the age of patients in group a (69.2±7.6) was significantly lower than that of patients in group b (72.1±7.2) and group c (72.5±6.7) (P=0.017). There were statistically significant differences in IPSS (P=0.010), IPSS-V (P=0.037), IPSS-S (P=0.022), QoL (P=0.038) and Qmax (P=0.037) among the groups a, b, and c after surgery. Moreover, IPSS, IPSS-V, IPSS-S and QoL were negatively correlated with TZV, while Qmax was positively correlated with TZV. Postoperative IPSS, IPSS-V, IPSS-S, QoL and Qmax were significantly different from those before surgery in groups A, B, C and groups a, b, c (P<0.001). Conclusion: TPV and TZV may not be significantly correlated with BPH symptoms, but may be correlated with age. TURP is an effective treatment for patients with different TPV and TZV. There is no significant statistical difference in the surgical efficacy among patients with different TPV, but patients with larger TZV tended to have better outcome. TZV may be better than TPV in predicting the postoperative efficacy.

[Application Value of Diagnostic TURP for Patients with Serum PSA Abnormality].

The value of transurethral cylindrical dilatation of the prostate in the treatment of patients with benign prostatic hyperplasia

The Role of diagnostic TURP in patients with elevated serum PSA levels BPH

High-risk benign prostatic hyperplasia patients treated with transurethral resection of prostate

The Diagnostic Value of Prostate Cancer Between Holmium Laser Enucleation of the Prostate and Transurethral Resection of the Prostate for Benign Prostatic Hyperplasia: A Retrospective Comparative Study

Application Value of "diagnostic" Transuretbral Resection Prostate in Patients with Negative Prostate Puncture Biopsy Combined with Lower Urinary Tract Symptoms

The role of TURP in early diagnosis of prostate carcinoma

Clinical Efficacy of TKRP Surgery and Its Effect on Serum PSA Level for Treating the Patients with Benign Prostatic Hyperplasia

Transurethral Resection of Prostate for Treatment of High-risk Patients with Large Volume Benign Prostatic Hyperplasia

The Clinical Research on the Change of the Patient's PSA Level after Trans-urethral Resection of Prostate (TURP)

Transurethral Resection of the the Prostate for Lower Urinary Tract Obstruction from Advanced Prostate Cancer

High Incidence of Incidental Prostate Cancer in Transurethral Resection of Prostate Specimens in China. the Value of Pathologic Review.

Predictive Value of Postoperative Ultrasonographic Parameters Regarding the Outcome after TURP for Patients with Symptomatic BPH

An evaluation of transurethral plasma kinetic resection versus transurethral resection of the prostate for the treatment of symptomatic BPH

Clinical Value of Anatomically Remove Apex of Prostate in TURP

Analysis of Improved Lower Urinary Tract Symptoms Following Transurethral Resection of Prostate

The Relevance Between the Serum PSA Level and the Prostatic Cancer Biopsy Detection Rate after Tamsulosin Treatment of Patients with Lower Urinary Tract Symptoms and Elevated PSA Level

[Combined Use of TUVP and TURP for Treating BPH (report of 179 Cases)].

Research on clinical application value of prostate specific antigen indexes in the differential diagnosis of benign prostatic hyperplasia and prostate cancer

[Changes of Urinary Symptoms after Transurethral Resection of the Prostate and Its Correlation with Clinical Parameters].

Effect of Total Prostate Volume and Transitional Zone Volume on the Curative Effect of Transurethral Resection of Prostate in Benign Prostatic Hyperplasia